Janna Gewirtz O’Brien, MD, FAAP, a fellow in the Department of Pediatrics, leads a team in a secondary data analysis of Minnesota youth. The findings suggest that primary care could act as a point of intervention for youth with unstable housing situations.
July is Minority Mental Health Awareness Month
According to the Kaiser Family Foundation, while sexual and gender minorities have many of the same health concerns as the general population, they experience certain health challenges at higher rates, and face several unique health challenges. Third-year post-doctoral researcher, Melissa Simone, PhD, agrees. As a queer woman, she is interested in understanding those differences, especially when it comes to her primary research focus area – eating disorders.
Tegan Carr, a first-year medical student at the Medical School’s Duluth campus, talks about how support from the Nancy I. English M.D. (‘92) Memorial Scholarship has encouraged her mid-career shift into medicine.
Bong Sook Jhun, PhD, FCVS, leads a team of researchers in examining the protective role that common PDE5 inhibitor medications might play during COVID-19 infection. If proven, these medications could potentially lead to milder symptoms, fewer hospitalizations, and quicker recoveries in COVID-19 patients with pre-existing heart and lung diseases.
Elizabeth Bradley, PhD, in the Department of Orthopedic Surgery studies the mechanisms that regulate age-related bone changes in women, focusing on protein phosphatase and enzyme histone deacetylase.
Mike Underwood, PhD, Branch Chief in CDC’s Division of Adolescent and School Health, may have first moved to Minnesota simply looking to earn a doctoral degree in pharmacology from the Department of Pharmacology, but he left the state after graduation with so much more—some lifelong friends, some invaluable skills and the ardent desire to pursue a career in an entirely different field.
Geoffrey Hart, PhD, in the Department of Medicine, and Marco Pravetoni, PhD, in the Department of Pharmacology, teamed up to develop a universal vaccine and monoclonal antibodies to protect against SARS-CoV-2 (COVID-19) and future emerging strains.
Muscular dystrophies are chronic degenerative diseases that can progress slowly over decades, and hence it can be difficult to decipher the pathological mechanisms at play.
A recurring observation in medical history is that with certain pandemics, groups of people experience associated neuropsychiatric symptoms, especially after they recover from the infection. As a clinician, Kathryn Cullen, MD, an associate professor in the Department of Psychiatry and Behavioral Sciences, has personally observed the toll that viral pandemics can have on someone’s mental health.
Kathryn Cullen, MD, in the Department of Psychiatry and Behavioral Sciences has been researching psychological and biological sequelae of COVID-19 in adolescents with and without non-suicidal self-injury.